Stem Cell Therapy Market Size to Hit USD 78.39 Billion by 2032, Growing at a CAGR of 22.8% from 2025 to 2032 | Coherent Market Insights

August 7, 2025 |

1 min read

According to Coherent Market Insights, the global Stem Cell Therapy Market is estimated to be valued at USD 18.61 Bn in 2025 and is expected to reach USD 78.39 Bn by 2032, exhibiting a compound annual growth rate (CAGR) of 22.8% from 2025 to 2032. The stem cell therapy market is experiencing significant growth due to rising demand for regenerative medicine, increasing prevalence of chronic and degenerative diseases, and advancements in stem cell research and technology. Expanding applications in neurology, orthopedics, and oncology, along with supportive government initiatives and funding, are driving market expansion. Moreover, the growing acceptance of personalized medicine and ongoing clinical trials are boosting the potential for innovative therapies, making stem cell therapy a rapidly evolving and high-demand sector in the global healthcare market.

Request Sample Report: https://www.coherentmarketinsights.com/insight/request-sample/2848

Global Stem Cell Therapy Market Key Takeaways

According to Coherent Market Insights (CMI), the global stem cell therapy market size is projected to quadruple, increasing from USD 18.61 Bn in 2025 to USD 78.39 Bn by 2032.

Global stem cell therapy demand is expected to rise at a robust CAGR of 22.8% during the forecast period.

Based on cell source, adult stem cells category is set to dominate the industry, capturing a market share of 44.2% in 2025.

Musculoskeletal disorders segment is slated to account for nearly two-fifths of the global stem cell therapy market share in 2025.

Hospitals, with an estimated market share of over one-third in 2025, are the leading end users of stem cell therapies.

North America is expected to maintain its monopoly during the assessment period, accounting for a prominent global share of 44.2% in 2025.

Asia Pacific is anticipated to emerge as the most lucrative market for stem cell therapy companies during the assessment period.

Immediate Delivery Available | Buy This Premium Research Report: https://www.coherentmarketinsights.com/insight/buy-now/2848

Increasing Prevalence of Chronic Diseases Fueling Market Growth

Coherent Market Insights’ latest stem cell therapy market research outlines key factors driving industry growth. Rising incidence of chronic diseases is one such prominent growth driver.

The global burden of chronic diseases such as cancer, diabetes, and neurological disorders continues to increase significantly. This trend is creating higher demand for innovative therapeutic solutions like stem cell therapy.

Stem cell therapies are taking the world of medicine by storm. They are igniting a new ray of hope to treat previously incurable diseases. These cells have the potential to develop into different cell types. Their growing usage for treating various chronic diseases is set to boost market growth during the forecast period.

High Cost of Stem Cell Therapies Hampering Market Growth

The future stem cell therapy market outlook looks bright, owing to increasing prevalence of chronic diseases and growing adoption of cell-based therapies. However, high cost of stem cell therapies remains a significant barrier to broader market growth.

Stem cell therapies are quite expensive due to the complexity of extraction, processing, and administration. This deters many patients from adopting these treatments, leading to reduced stem cell therapy market demand.

Also Read: Stem Cells Market Size, Share, Trends & Opportunities for 2025-2032

Advancements in Stem Cell Technologies Unlocking New Opportunities

Continuous technological advancements have enhanced understanding, isolation, and application of stem cells. These developments are enabling companies to create advanced stem cell therapies for a wide range of conditions, including cancer and Parkinson’s disease. Expanding therapeutic applications are expected to open new revenue streams for stem cell therapy companies.

Advanced gene-editing tools like CRISPR-Cas9 are enhancing the precision and efficacy of stem cell therapies. Similarly, 3D bioprinting is being explored for its potential in tissue engineering as well as organ regeneration.

Moreover, huge investments are being made by governments, private investors, and pharmaceutical companies in stem cell research. This growing funding supports clinical trials, technological advancements, and the development of new therapies. As a result, the future outlook for the stem cell therapy market appears promising.

Also Read: Induced Pluripotent Stem Cells Market Analysis and Forecast for 2025-2032

Impact of AI on the Stem Cell Therapy Market

Artificial Intelligence (AI) is significantly transforming the stem cell therapy market. It accelerates research, improves diagnostic precision, and optimizes treatment outcomes.

AI-powered algorithms assist in identifying optimal stem cell candidates, predicting patient responses, and personalizing therapy protocols. Similarly, AI streamlines data analysis in clinical trials, thereby reducing development time and costs.

Advanced technologies like AI are enhancing the efficiency of stem cell therapy development. They have the potential to drive innovation as well as expand accessibility of stem cell therapies in regenerative medicine.

Emerging Stem Cell Therapy Market Trends

Growing demand for regenerative medicine is a key growth-shaping trend in the stem cell therapy market. Stem cell therapies remain at the heart of regenerative medicine, offering solutions for tissue regeneration, wound healing, and organ repair. As the demand for regenerative medicine increases, so will sales of stem cell therapies.

Stem cell therapies are being gradually adopted across multiple medical specialties, including orthopedics, cardiology, neurology, oncology, and dermatology. These expanding applications are expected to boost the stem cell therapy market value during the forecast period.

Rising interest in personalized medicine is also stimulating the stem cell therapy market growth. Stem cells enable development of customized therapies tailored to individual patient profiles. Their ability to support the growing trend of personalized medicine is expected to drive demand.

Allogeneic stem cell therapies are gaining immense traction in the market due to ease of production, scalability, and off-the-shelf availability. This shift towards allogeneic therapies is likely to facilitate expansion of the stem cell therapy market.

Request For Customization: https://www.coherentmarketinsights.com/insight/request-customization/2848

Analyst’s View

“The global stem cell therapy market is set for rapid expansion, owing to growing incidence of chronic diseases, increasing acceptance of cell-based therapies, and advancements in stem cell technologies,” said senior analyst Nikhilesh Ravindra Patel.

Current Events and Their Impact on the Stem Cell Therapy Market

Event	Description and Impact
FDA’s Updated Guidance on Stem Cell Clinical Trials	Description: The FDA recently issued updated guidance requiring more rigorous long-term follow-up (LTFU) in stem cell-based gene therapy trials, especially involving genome editing or integration (e.g., CRISPR). Impact: This will likely improve public trust and investor confidence by emphasizing patient safety.
Expanded Medicare Coverage by CMS for HSCT	Description: In March 2024, CMS expanded Medicare coverage for allogeneic hematopoietic stem cell transplantation (HSCT) in patients with myelodysplastic syndromes (MDS) meeting specific prognostic scores. Impact: The expansion supports greater access to life-extending therapies, boosts demand for HSCT, and may drive clinical innovation.
Japan’s Sumitomo Pharma Seeks Approval for Groundbreaking Stem Cell Therapy for Parkinson’s (August 2025)	Description: Sumitomo Pharma recently submitted an application in Japan for manufacturing and marketing of an iPS cell‑based treatment targeting advanced Parkinson’s disease. Impact: If approved, this would mark one of the first commercial applications of iPSC technology for neurodegenerative diseases, potentially accelerating the adoption of stem cell therapies globally and stimulating further R&D investment.

Competitor Insights
Key companies in stem cell therapy market report:

- Kolon TissueGene, Inc.

- Osiris Therapeutics, Inc.

- Cellular Biomedicine Group

- Anterogen Co. Ltd.

- Athersys Inc.

- JCR Pharmaceuticals Co., Ltd.

- Pharmicell Co., Inc.

- Magellan

- Stemedica Cell Technologies, Inc.

- Biorestorative Therapies Inc.

- Medipost Co., Ltd.

- Brainstorm Cell Limited.

- ViaCyte Inc.

- NuVasive Inc.

- ANTEROGEN. C.O., LTD.

- AlloSource

- RTI Surgical

Key Developments

In August 2025 – Sumitomo Pharma submitted an application in Japan for manufacturing and marketing of a groundbreaking stem cell therapy for advanced Parkinson’s disease. The submission follows a successful clinical trial, setting new standards in Parkinson's disease therapeutics.

In June 2025, Gilead’s CAR-T cell therapy demonstrated positive results in treating deadly brain cancer. The findings signal a potential breakthrough in the battle against aggressive glioblastomas.

In July 2024, Bioserve India launched advanced stem cell products nationwide. Developed by REPROCELL, these products aim to drive innovation in scientific research and drug development. They are expected to boost progress in regenerative medicine and therapeutic discovery in the Indian market.

Market Segmentation

Cell Source Insights (Revenue, USD Bn, 2020 - 2032)

Adult Stem Cells

Induced Pluripotent Stem Cells

Embryonic Stem Cells

Others

Application Insights (Revenue, USD Bn, 2020 - 2032)

Musculoskeletal Disorders

Wounds and Injuries

Cancer

Autoimmune Disorders

Others

End User Insights (Revenue, USD Bn, 2020 - 2032)

Hospitals

Cell Banks

Academic and Research Institutes

Regional Insights (Revenue, USD Bn, 2020 - 2032)

North America

Latin America

Europe

Asia Pacific

Middle East

Africa

Also Read: Stem Cell Manufacturing Market Size, Share & Trend Analysis Report for 2025-2032

Our Trusted Partners:
Worldwide Market Reports, Coherent MI, Stratagem Market Insights
Get Recent News:
https://www.coherentmarketinsights.com/news

About Us:
Coherent Market Insights leads into data and analytics, audience measurement, consumer behaviors, and market trend analysis. From shorter dispatch to in-depth insights, CMI has exceled in offering research, analytics, and consumer-focused shifts for nearly a decade. With cutting-edge syndicated tools and custom-made research services, we empower businesses to move in the direction of growth. We are multifunctional in our work scope and have 450+ seasoned consultants, analysts, and researchers across 26+ industries spread out in 32+ countries.

Contact Us:
Mr. Shah
Coherent Market Insights
533 Airport Boulevard,
Suite 400, Burlingame,
CA 94010, United States
US: + 12524771362
UK: +442039578553
AUS: +61-2-4786-0457
India: +91-848-285-0837
Email: sales@coherentmarketinsights.com
Website: https://www.coherentmarketinsights.com
For Latest Update Follow Us:
LinkedIn | Facebook | Twitter